- Home
- TRML vs FOF Comparison
TRML vs FOF Comparison
Compare TRML & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- FOF
- Stock Information
- Founded
- TRML 2021
- FOF 2006
- Country
- TRML United States
- FOF United States
- Employees
- TRML N/A
- FOF N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- FOF Investment Managers
- Sector
- TRML Health Care
- FOF Finance
- Exchange
- TRML Nasdaq
- FOF Nasdaq
- Market Cap
- TRML 419.1M
- FOF 357.1M
- IPO Year
- TRML N/A
- FOF N/A
- Fundamental
- Price
- TRML $23.01
- FOF $13.12
- Analyst Decision
- TRML Strong Buy
- FOF
- Analyst Count
- TRML 3
- FOF 0
- Target Price
- TRML $65.00
- FOF N/A
- AVG Volume (30 Days)
- TRML 187.7K
- FOF 58.7K
- Earning Date
- TRML 11-07-2024
- FOF 01-01-0001
- Dividend Yield
- TRML N/A
- FOF 9.07%
- EPS Growth
- TRML N/A
- FOF N/A
- EPS
- TRML N/A
- FOF N/A
- Revenue
- TRML N/A
- FOF N/A
- Revenue This Year
- TRML N/A
- FOF N/A
- Revenue Next Year
- TRML N/A
- FOF N/A
- P/E Ratio
- TRML N/A
- FOF N/A
- Revenue Growth
- TRML N/A
- FOF N/A
- 52 Week Low
- TRML $12.12
- FOF $9.59
- 52 Week High
- TRML $48.31
- FOF $11.75
- Technical
- Relative Strength Index (RSI)
- TRML 37.25
- FOF 59.17
- Support Level
- TRML $25.58
- FOF $12.70
- Resistance Level
- TRML $27.51
- FOF $12.84
- Average True Range (ATR)
- TRML 1.81
- FOF 0.18
- MACD
- TRML -0.61
- FOF 0.01
- Stochastic Oscillator
- TRML 10.76
- FOF 74.68
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.